Earnings calendar/RLAY
Relay Therapeutics, Inc. (RLAY)
Pre-earnings consensus targets and post-earnings beat/miss — standardized metrics from the earnings calendar. No narrative, no price targets.
Pre-earnings
Consensus targets for the next print, plus how the business has been running.
Next report
Nov 5, 2026
Consensus estimate row
EPS target
$-0.39
Street estimate
Revenue target
$1.5M
Street estimate
Trailing EPS (avg 4Q)
$-0.39
Beat rate last 4: 25%
Latest EPS YoY
0.0%
vs 2025-08-07
Latest revenue YoY
-48.3%
How results look so far
Trailing revenue (avg 4Q)
$3.5M
Printed quarters
EPS beat rate (4Q)
25%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Aug 6, 2026
EPS miss
EPS actual / est
$-0.41 / $-0.39
-4.8%
Revenue actual / est
$350,000 / $960,000
-63.5%
Result
Below target
Based on EPS vs consensus
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 11/5/2026upcoming | $-0.39 | Pending | — | $1.5M | Pending | — |
| 8/6/2026 | $-0.39 | $-0.41 | -4.8% | $960,000 | $350,000 | -63.5% |
| 5/5/2026 | $-0.35 | $-0.41 | -17.1% | $5.6M | $3.0M | -46.2% |
| 5/4/2026upcoming | $-0.35 | Pending | — | $5.6M | Pending | — |
| 2/26/2026 | $-0.38 | $-0.32 | +15.8% | $5.0M | $7.0M | +41.0% |
| 2/25/2026upcoming | $-0.38 | Pending | — | — | Pending | — |
| 11/6/2025 | $-0.39 | $-0.43 | -10.3% | $5.0M | Pending | — |
| 8/7/2025 | $-0.49 | $-0.41 | +16.3% | $14,290 | $677,000 | +4637.6% |
| 5/5/2025 | $-0.50 | $-0.46 | +8.0% | $3.8M | $7.7M | +104.1% |
| 2/26/2025 | $-0.57 | $-0.45 | +21.1% | $5.5M | Pending | — |
| 11/6/2024 | $-0.77 | $-0.63 | +18.2% | $66,670 | Pending | — |
| 8/6/2024 | $-0.73 | $-0.69 | +5.5% | $80,000 | Pending | — |
| 5/2/2024 | $-0.70 | $-0.62 | +11.4% | $30,000 | $10.0M | +33256.7% |
| 2/22/2024 | $-0.76 | $-0.67 | +11.8% | $130,000 | $1,000 | -99.2% |
| 11/2/2023 | $-0.83 | $-0.54 | +34.9% | $370,000 | $25.2M | +6711.4% |
| 8/8/2023 | $-0.78 | $-0.81 | -3.8% | $750,000 | $119,000 | -84.1% |
| 5/4/2023 | $-0.70 | $-0.78 | -11.4% | $190,000 | $226,000 | +18.9% |
| 2/23/2023 | $-0.71 | $-0.56 | +21.1% | $271,429 | $253,000 | -6.8% |
| 11/3/2022 | $-0.71 | $-0.76 | -7.0% | $1.8M | $344,000 | -80.9% |
| 8/4/2022 | $-0.62 | $-0.71 | -14.5% | $2.1M | $365,000 | -82.5% |
| 5/5/2022 | $-0.63 | $-0.61 | +3.2% | $166,667 | $419,000 | +151.4% |
| 2/24/2022 | $-0.60 | $-0.59 | +1.7% | $3.8M | $567,000 | -85.2% |
| 11/10/2021 | $-0.65 | $-0.66 | -1.5% | $655,753 | $666,000 | +1.6% |
| 8/12/2021 | $-0.48 | $-2.10 | -337.5% | $844,000 | $844,000 | 0.0% |
| 5/13/2021 | $-0.48 | $-0.47 | +2.1% | $971,833 | $952,000 | -2.0% |
| 3/25/2021 | $0.17 | $0.70 | +311.8% | — | $82.7M | — |
| 11/12/2020 | $-0.35 | $-0.51 | -45.7% | — | Pending | — |
| 8/27/2020 | $-0.66 | $-6.06 | -818.2% | — | Pending | — |
| 7/9/2020 | — | $-5.99 | — | — | Pending | — |
| 12/31/2019 | — | $-6.24 | — | — | Pending | — |
| 9/30/2019 | — | $-5.53 | — | — | Pending | — |
| 6/30/2019 | — | $-5.28 | — | — | Pending | — |
| 3/31/2019 | — | $-4.59 | — | — | Pending | — |